The British government could order 50 million doses of the new GSK vaccineA new Covid vaccine developed by the British drugmaker GlaxoSmithKline and a German partner has produced good results in initial laboratory tests, the companies said. The mRNA technology at the heart of the jab could be used to create a so-called multivalent vaccine, they said, which would be designed to protect against several virus variants. SponsoredHuman trials are expected to begin later this year and the British government said in February that it could order 50 million doses. In the spring ministers suggested the project would lead to the UK developing the ability to manufacture its own mRNA vaccines. At present, Britain is relying on mRNA vaccines produced overseas — chiefly by Pfizer in Belgium — to vaccinate people under 40.

Source: The Times August 17, 2021 10:52 UTC